AlloVir

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch AlloVir and buy or sell other stocks, ETFs, and their options commission-free!

About ALVR

AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. 

CEO
Vikas Sinha, MBA, CPA
CEOVikas Sinha, MBA, CPA
Employees
6
Employees6
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2013
Founded2013
Employees
6
Employees6

ALVR Key Statistics

Market cap
49.45M
Market cap49.45M
Price-Earnings ratio
-0.89
Price-Earnings ratio-0.89
Dividend yield
—
Dividend yield—
Average volume
30.33K
Average volume30.33K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$24.15
52 Week high$24.15
52 Week low
$7.96
52 Week low$7.96
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.